NeuroKaire Co-Founder on Channel 10: Advancing Personalized Psychiatry

NeuroKaire Co-founder and CSO Dr. Daphna Laifenfeld appeared on Channel 10 to share how the company is transforming mental health treatment through personalized, neuron-based technology.

Depression
Mental Health
Neuroscience
Precision Medicine
WriTten By
Published date
Jun 8, 2025
Source

Dr. Daphna Laifenfeld, CSO and Co-Founder of NeuroKaire, was featured on Channel 10 News in a televised interview highlighting the promise of precision psychiatry. In the segment, Daphna discusses how NeuroKaire’s groundbreaking platform—powered by patient-derived neurons and advanced AI—has the potential to transform how depression is treated. By helping clinicians personalize care based on each individual’s biology, the technology supports more targeted treatment decisions and increases the likelihood of better outcomes for patients.

Her appearance also contributes to the growing global conversation around the mental health crisis, emphasizing the urgent need for more data-driven, individualized solutions to treat depression effectively. This spotlight on Daphna’s leadership and NeuroKaire’s mission on national television reflects the broader movement to make mental health care more precise, compassionate, and impactful.

Read more here: https://tv10.co.il/israel/35194/

Watch the full video here: https://www.youtube.com/watch?v=w7dNLsOGm6c

Previous Article
Next Article

Contact Us

New Jersey Office

78 John Miller Way,
Kearny, NJ 07032, USA

Tel Aviv Office

Yigal Alon Street 126
Tel Aviv-Yafo, Israel

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.